Princeton, NJ, United States of America

Guillaume Chabin

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Princeton Junction, NJ (US) (2020)
  • Princeton, NJ (US) (2021)
  • Paris, FR (2022 - 2023)

Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Innovations by Guillaume Chabin in Medical Imaging

Introduction

Guillaume Chabin is a notable inventor based in Princeton, NJ (US), recognized for his contributions to the field of medical imaging. With a total of five patents to his name, Chabin has made significant strides in developing systems and methods that enhance the assessment of diseases, particularly in the context of COVID-19.

Latest Patents

One of Chabin's latest patents focuses on the medical image synthesis of abnormality patterns associated with COVID-19. This innovation provides systems and methods for generating a synthesized medical image. The process begins with receiving an input medical image, followed by the generation of a synthesized segmentation mask. The input medical image is then masked based on this segmentation mask, resulting in a masked input medical image that contains both unmasked and masked portions. An initial synthesized medical image is created using a trained machine learning-based generator network, which includes a synthesized version of the unmasked portion and synthesized patterns in the masked portion. Ultimately, these synthesized patterns are fused with the input medical image to produce a final synthesized medical image.

Another significant patent by Chabin involves the assessment of abnormality regions associated with diseases from chest CT images. This patent outlines systems and methods for evaluating a disease by receiving medical imaging data of a patient's lungs. The lungs are segmented from this data, and abnormality regions associated with a disease are identified. The assessment of the disease is determined based on the segmented lungs and abnormality regions, which may include COVID-19, SARS, MERS, or other types of pneumonia.

Career Highlights

Guillaume Chabin is currently employed at Siemens Healthcare GmbH, where he continues to innovate in the medical imaging sector. His work has been instrumental in advancing technologies that aid in the diagnosis and treatment of respiratory diseases.

Collaborations

Chabin collaborates with esteemed colleagues such as Sasa Grbic and Zhoubing Xu, contributing to a dynamic team focused on pushing the boundaries of medical imaging technology.

Conclusion

Guillaume Chabin's innovative work in medical imaging, particularly in relation to COVID-19, showcases his commitment to improving healthcare through technology. His patents reflect a deep understanding of the challenges in medical diagnostics and a dedication to finding effective solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…